KFDA to exempt drug reviews on newly registered items.

Published: 2004-05-28 06:59:00

Updated: 2004-05-28 06:59:00

KFDA disclosed in public the draft of the Drug Review regulation and Narcotic Drug Act on May 24 purported to revise relevant provisions pertaining to the drug review and narcotic drug controls in its terminology and other operational weakness surfaced during the implementation of the provision.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK